Subjects: Clinical Trials as Topic and Cost-Benefit Analysis / Copyright: Copyright may apply - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Clinical Trials as Topic ✖ Subjects Cost-Benefit Analysis ✖ Copyright Copyright may apply ✖

1. Palliative care in the outpatient setting: a comparative effectiveness report : final report

Author(s):: Cunningham, Courtney, author
Trevers, Karin, author
Chapman, Rick, author
Loos, Anne, author
Lawler, Erin, author
Liu, Shanshan, author
Pearson, Steven D., author
Ollendorf, Daniel A., author
Publication:: Boston, MA : Institute for Clinical and Economic Review, April 27, 2016
Subject(s):: Ambulatory Care -- organization & administration
Comparative Effectiveness Research
Palliative Care -- organization & administration
Anxiety -- therapy
Caregivers
Clinical Trials as Topic
Cost Savings
Cost-Benefit Analysis
Depression -- therapy
Health Policy
Health Resources -- utilization
Health Services Accessibility
Healthcare Disparities
Insurance, Health, Reimbursement
Medicaid -- economics
Medicare -- economics
Outcome Assessment (Health Care)
Palliative Care -- manpower
Patient Education as Topic
Patient Satisfaction
Quality of Life
Research
Spirituality
Humans
United States

2. Chimeric antigen receptor T-cell therapy for B-cell cancers: effectiveness and value : final evidence report

Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, March 23, 2018
Subject(s):: Immunotherapy, Adoptive
Leukemia, B-Cell -- drug therapy
Lymphoma, B-Cell -- drug therapy
Lymphoma, Non-Hodgkin -- drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
Adult
Child
Clinical Trials as Topic
Clofarabine -- therapeutic use
Cost-Benefit Analysis
Immunotherapy, Adoptive -- adverse effects
Immunotherapy, Adoptive -- economics
Receptors, Chimeric Antigen -- therapeutic use
Treatment Outcome
Humans
United States

3. Modulator treatments for cystic fibrosis: effectiveness and value : final evidence report and meeting summary

Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, June 7, 2018
Subject(s):: Cystic Fibrosis -- drug therapy
Cystic Fibrosis Transmembrane Conductance Regulator -- therapeutic use
Clinical Trials as Topic
Cost of Illness
Cost-Benefit Analysis
Cystic Fibrosis Transmembrane Conductance Regulator -- adverse effects
Treatment Outcome
Humans
United States

4. Targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis: effectiveness and value : condition update : final evidence report

Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, August 3, 2018
Subject(s):: Immunologic Factors -- therapeutic use
Immunomodulation
Psoriasis -- drug therapy
Certolizumab Pegol -- therapeutic use
Clinical Trials as Topic
Cost-Benefit Analysis
Immunologic Factors -- adverse effects
Immunologic Factors -- economics
Quality of Life
Treatment Outcome
Humans
United States

5. Inotersen and patisiran for hereditary transthyretin amyloidosis: effectiveness and value : final evidence report

Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, October 4, 2018
Subject(s):: Amyloidosis, Familial -- drug therapy
RNA, Small Interfering -- therapeutic use
Amyloid Neuropathies, Familial -- drug therapy
Amyloidosis, Familial -- complications
Clinical Trials as Topic
Cost-Benefit Analysis
RNA, Small Interfering -- adverse effects
RNA, Small Interfering -- economics
Treatment Outcome
Humans
United States

6. Excluding older, sicker patients from clinical trials: issues, concerns, and solutions

Publication:: Washington, D.C. : AARP Public Policy Institute, c2011
Subject(s):: Clinical Trials as Topic
Patient Selection
Randomized Controlled Trials as Topic
Aged
Aged, 80 and over
Chronic Disease
Cost-Benefit Analysis
Frail Elderly
Sample Size
Selection Bias
Humans
United States